WebbSalarius Pharmaceuticals, Inc. Common Stock (SLRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Webb2 mars 2024 · SLRX:NAQ price falls below 50-day moving average to 2.10 at 11:02 GMT February 28, 2024. SLRX:NAQ trading volume exceeds daily average by +21.35% February 27, 2024. SLRX:NAQ price rises above 15-day moving average to 2.20 at 10:13 GMT yesterday. SLRX:NAQ price rises above 15-day moving average to 2.19 at 15:25 GMT …
Salarius Pharmaceuticals Stock (NASDAQ:SLRX), Quotes and …
Webb1 aug. 2024 · A company might sell a stock warrant with an expiration date that is up to 15 years away. Options, on the other hand, expire either in three, six, nine months, 1 year, or … Webb27 jan. 2024 · (NASDAQ: SLRX), a clinical-stage biopharmaceutical company using protein inhibition and protein degradation to develop cancer therapies for patients in need of new treatment options, announces the receipt of a $1.48 million January 27, 2024 Salarius Pharmaceuticals Presents SP-3164 Preclini... hop-o\\u0027-my-thumb hy
Salarius Pharmaceuticals files for resale of 7M shares by selling ...
Webb17 mars 2024 · SLRX U.S.: Nasdaq Salarius Pharmaceuticals Inc. Watch list Create SLRX Alert After Hours Last Updated: Mar 17, 2024 7:50 p.m. EDT Delayed quote $ 2.0700 0.07 3.50% After Hours Volume: 200... WebbLadenburg Thalmann & Co. Inc. is acting as the exclusive placement agent for the transaction. Salarius reduced the exercise price of Exercising Holders’ warrants from … Webb7 feb. 2024 · In addition, Salarius has granted the underwriter a 45-day option to purchase up to 1,252,173 additional shares of common stock and/or warrants to purchase up to … hop-o\u0027-my-thumb hh